Differential exposure biomarker levels among cigarette smokers and smokeless tobacco consumers in the National Health and Nutrition Examination Survey 1999–2008

References

• Albertini R, Bird M, Doerrer N, Needham L, Robison S, Sheldon L, Zenick H. (2006). The use of biomonitoring data in exposure and human health risk assessments. Environ Health Perspect 114:1755–1762.
   PubMed Web of Science ®Google Scholar
• Alexandrie AK, Warholm M, Carstensen U, Axmon A, Hagmar L, Levin JO, Ostman C, Rannug A. (2000). CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure. Carcinogenesis 21:669–676.
   PubMed Web of Science ®Google Scholar
• Apostoli P, Neri G, Lucas D, Manno M, Berthou F. (2003). Influence of genetic polymorphisms of CYP1A1 and GSTM1 on the urinary levels of 1-hydroxypyrene. Toxicol Lett 144:27–34.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Jacob P 3rd, Yu L. (1989). Daily use of smokeless tobacco: systemic effects. Ann Intern Med 111:112–116.
   PubMed Web of Science ®Google Scholar
• Buratti M, Pellegrino O, Brambilla G, Colombi A. (2000). Urinary excretion of 1-hydroxypyrene as a biomarker of exposure to polycyclic aromatic hydrocarbons from different sources. Biomarkers 5:368–381.
   PubMed Web of Science ®Google Scholar
• CDC (Centers for Disease Control and Prevention). (2009a). National Health and Nutrition Examination Survey, What’s New Archive, July 2009. Available at: http://www.cdc.gov/nchs/nhanes/archive_new_nhanes.htm [accessed May 2010]
   Google Scholar
• CDC (Centers for Disease Control and Prevention). (2009b). Fourth national report on human exposure to environmental chemicals. Department of Health and Human Services. Available at: http://www.cdc.gov/exposurereport/pdf/FourthReport.pdf [accessed May 2010]
   Google Scholar
• CDC (Centers for Disease Control and Prevention). (2010a). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Available at: http://www.cdc.gov/nchs/nhanes.htm [accessed May 2010]
   Google Scholar
• CDC (Centers for Disease Control and Prevention). (2010b). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol). Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Available: http://www.cdc.gov/nchs/nhanes.htm [accessed May 2010]
   Google Scholar
• Diekmann J, Wittig A, Stabbert R. (2008). Gas chromatographic-mass spectrometric analysis of acrylamide and acetamide in cigarette mainstream smoke after on-column injection. J Chromatogr Sci 46:659–663.
   PubMed Web of Science ®Google Scholar
• Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt RD. (2004). Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users. Addict Behav 29:349–355.
   PubMed Web of Science ®Google Scholar
• Ellingsen DG, Thomassen Y, Rustad P, Molander P, Aaseth J. (2009). The time-trend and the relation between smoking and circulating selenium concentrations in Norway. J Trace Elem Med Biol 23:107–115.
   PubMed Web of Science ®Google Scholar
• Gebel TW, Suchenwirth RH, Bolten C, Dunkelberg HH. (1998). Human biomonitoring of arsenic and antimony in case of an elevated geogenic exposure. Environ Health Perspect 106:33–39.
   PubMed Web of Science ®Google Scholar
• Hajimiragha H, Ewers U, Brockhaus A, Boettger A. (1989). Levels of benzene and other volatile aromatic compounds in the blood of non-smokers and smokers. Int Arch Occup Environ Health 61:513–518.
   PubMed Web of Science ®Google Scholar
• Hecht SS. (2002). Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23:907–922.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Murphy SE, Riley WT, Le C, Luo X, Mooney M, Hatsukami DK. (2007). Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomarkers Prev 16:1567–1572.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Stepanov I, Jensen J, Anderson A, Hatsukami DK. (2008). Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users. Cancer Epidemiol Biomarkers Prev 17:732–735.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Ye M, Le KA, Jensen JA, Zimmerman CL, Hatsukami DK. (2002). Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Res 62:129–134.
   PubMed Web of Science ®Google Scholar
• Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, Duell EJ. (2009). Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect 117:1718–1723.
   PubMed Web of Science ®Google Scholar
• Heudorf U, Angerer J. (2001). Urinary monohydroxylated phenanthrenes and hydroxypyrene–the effects of smoking habits and changes induced by smoking on monooxygenase-mediated metabolism. Int Arch Occup Environ Health 74:177–183.
   PubMed Web of Science ®Google Scholar
• Hoffmann D, Adams JD, Lisk D, Fisenne I, Brunnemann KD. (1987). Toxic and carcinogenic agents in dry and moist snuff. J Natl Cancer Inst 79:1281–1286.
   PubMedGoogle Scholar
• IARC. (2004). Tobacco and Involuntary Smoking. IARC Monogr Eval Carcinog Risks Hum 83:1452.
   Google Scholar
• IARC. (2007). Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum 89:626.
   Google Scholar
• Jacob J, Grimmer G, Dettbarn G. (1999). Profile of urinary phenanthrene metabolites in smokers and non-smokers. Biomarkers 4:319–327.
   PubMed Web of Science ®Google Scholar
• Kafai MR, Ganji V. (2003). Sex, age, geographical location, smoking, and alcohol consumption influence serum selenium concentrations in the USA: third National Health and Nutrition Examination Survey, 1988-1994. J Trace Elem Med Biol 17:13–18.
   PubMed Web of Science ®Google Scholar
• Kresty LA, Carmella SG, Borukhova A, Akerkar SA, Gopalakrishnan R, Harris RE, Stoner GD, Hecht SS. (1996). Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia. Cancer Epidemiol Biomarkers Prev 5:521–525.
   PubMed Web of Science ®Google Scholar
• Lee DH, Jacobs DR, Kocher T. (2008). Associations of serum concentrations of persistent organic pollutants with the prevalence of periodontal disease and subpopulations of white blood cells. Environ Health Perspect 116:1558–1562.
   PubMed Web of Science ®Google Scholar
• Lin YS, Egeghy PP, Rappaport SM. (2008). Relationships between levels of volatile organic compounds in air and blood from the general population. J Expo Sci Environ Epidemiol 18:421–429.
   PubMed Web of Science ®Google Scholar
• Lumley T.(2010). R package version 3.22-1. Survey: analysis of complex survey samples. Available at: http://faculty.washington.edu/tlumley/survey/ [accessed March 2010]
   Google Scholar
• Maier RH, Bray JT, Pories WJ. (1989). Trace element status of some commercial smokeless tobaccos. J Toxicol Environ Health 28:171–181.
   PubMed Web of Science ®Google Scholar
• Manini P, De Palma G, Andreoli R, Poli D, Mozzoni P, Folesani G, Mutti A, Apostoli P. (2006). Environmental and biological monitoring of benzene exposure in a cohort of Italian taxi drivers. Toxicol Lett 167:142–151.
   PubMed Web of Science ®Google Scholar
• Manini P, De Palma G, Andreoli R, Poli D, Petyx M, Corradi M, Mutti A, Apostoli P. (2008). Biological monitoring of low benzene exposure in Italian traffic policemen. Toxicol Lett 181:25–30.
   PubMedGoogle Scholar
• Mannino DM, Homa DM, Matte T, Hernandez-Avila M. (2005). Active and passive smoking and blood lead levels in U.S. adults: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res 7:557–564.
   PubMed Web of Science ®Google Scholar
• McKelvey W, Gwynn RC, Jeffery N, Kass D, Thorpe LE, Garg RK, Palmer CD, Parsons PJ. (2007). A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults. Environ Health Perspect 115:1435–1441.
   PubMed Web of Science ®Google Scholar
• Murphy SE, Link CA, Jensen J, Le C, Puumala SS, Hecht SS, Carmella SG, Losey L, Hatsukami DK. (2004). A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers. Cancer Epidemiol Biomarkers Prev 13:1617–1623.
   PubMed Web of Science ®Google Scholar
• Nan HM, Kim H, Lim HS, Choi JK, Kawamoto T, Kang JW, Lee CH, Kim YD, Kwon EH. (2001). Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations. Carcinogenesis 22:787–793.
   PubMed Web of Science ®Google Scholar
• NCI (National Cancer Institute). (1999). Health effects of exposure to environmental tobacco smoke (Smoking and Tobacco Control Monograph no. 10). Bethesda, MD: National Cancer Institute. Available at: http://cancercontrol.cancer.gov/tcrb/monographs/10/ [accessed May 2010]
   Google Scholar
• Pappas RS, Stanfill SB, Watson CH, Ashley DL. (2008). Analysis of toxic metals in commercial moist snuff and Alaskan iqmik. J Anal Toxicol 32:281–291.
   PubMed Web of Science ®Google Scholar
• Pérez HL, Osterman-Golkar S. (2003). A sensitive gas chromatographic-tandem mass spectrometric method for detection of alkylating agents in water: application to acrylamide in drinking water, coffee and snuff. Analyst 128:1033–1036.
   PubMed Web of Science ®Google Scholar
• Richter PA, Bishop EE, Wang J, Swahn MH. (2009). Tobacco smoke exposure and levels of urinary metals in the U.S. youth and adult population: the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Int J Environ Res Public Health 6:1930–1946.
   PubMed Web of Science ®Google Scholar
• Rodgman A, Perfetti TA.(2009). The chemical components of tobacco and tobacco smoke. Boca Raton, FL: Taylor & Francis.
   Google Scholar
• Roethig HJ, Munjal S, Feng S, Liang Q, Sarkar M, Walk RA, Mendes PE. (2009). Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers. Nicotine Tob Res 11:1216–1225.
   PubMed Web of Science ®Google Scholar
• Santamaria A, Ferriby L, Harris M, Paustenbach D. (2006). Use of Biomarkers in Health Risk Assessment. In: DeCaprio AP, editor. Toxicologic biomarkers. New York: Taylor & Francis, xii, 295 p.
   Google Scholar
• Scherer G. (2005). Biomonitoring of inhaled complex mixtures–ambient air, diesel exhaust and cigarette smoke. Exp Toxicol Pathol 57 Suppl 1:75–110.
   PubMedGoogle Scholar
• Scherer G, Frank S, Riedel K, Meger-Kossien I, Renner T. (2000). Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiol Biomarkers Prev 9:373–380.
   PubMed Web of Science ®Google Scholar
• Sexton K. (2006). Biomarkers of Toxicant Exposure. In: DeCaprio AP, editor. Toxicologic biomarkers. New York: Taylor & Francis, xii, 295 p.
   Google Scholar
• Shaham J, Meltzer A, Ashkenazi R, Ribak J. (1996). Biological monitoring of exposure to cadmium, a human carcinogen, as a result of active and passive smoking. J Occup Environ Med 38:1220–1228.
   PubMed Web of Science ®Google Scholar
• Smith KM, Barraj LM, Kantor M, Sahyoun NR. (2009). Relationship between fish intake, n-3 fatty acids, mercury and risk markers of CHD (National Health and Nutrition Examination Survey 1999-2002). Public Health Nutr 12:1261–1269.
   PubMed Web of Science ®Google Scholar
• Stepanov I, Upadhyaya P, Carmella SG, Feuer R, Jensen J, Hatsukami DK, Hecht SS. (2008). Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers. Cancer Epidemiol Biomarkers Prev 17:1764–1773.
   PubMed Web of Science ®Google Scholar
• Stepanov I, Villalta PW, Knezevich A, Jensen J, Hatsukami D, Hecht SS. (2010). Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry. Chem Res Toxicol 23:66–73.
   PubMed Web of Science ®Google Scholar
• Vesper HW, Bernert JT, Ospina M, Meyers T, Ingham L, Smith A, Myers GL. (2007). Assessment of the relation between biomarkers for smoking and biomarkers for acrylamide exposure in humans. Cancer Epidemiol Biomarkers Prev 16:2471–2478.
   PubMed Web of Science ®Google Scholar
• Vesper HW, Caudill SP, Osterloh JD, Meyers T, Scott D, Myers GL. (2010). Exposure of the U.S. population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004. Environ Health Perspect 118:278–283.
   PubMed Web of Science ®Google Scholar
• Wei W, Kim Y, Boudreau N. (2001). Association of smoking with serum and dietary levels of antioxidants in adults: NHANES III, 1988-1994. Am J Public Health 91:258–264.
   PubMed Web of Science ®Google Scholar
• Willers S, Attewell R, Bensryd I, Schutz A, Skarping G, Vahter M. (1992). Exposure to environmental tobacco smoke in the household and urinary cotinine excretion, heavy metals retention, and lung function. Arch Environ Health 47:357–363.
   PubMed Web of Science ®Google Scholar
• Wilson CL, Bodnar JA, Brown BG, Morgan WT, Potts RJ, Borgerding MF. (2008). Assessment of dioxin and dioxin-like compounds in mainstream smoke from selected US cigarette brands and reference cigarettes. Food Chem Toxicol 46:1721–1733.
   PubMed Web of Science ®Google Scholar
• Yang M, Koga M, Katoh T, Kawamoto T. (1999). A study for the proper application of urinary naphthols, new biomarkers for airborne polycyclic aromatic hydrocarbons. Arch Environ Contam Toxicol 36:99–108.
   PubMed Web of Science ®Google Scholar